[25-NSE] Cartesian Growth Corporation II Warrant SEC Filing

Rhea-AI Filing Summary

AeroVironment, Inc. (NASDAQ: AVAV) filed an 8-K to report the closing of the underwriters’ full exercise of the 15% over-allotment option related to its July 3, 2025 common-stock offering. On July 15, 2025 the company issued 529,234 additional shares at the original offering price of $248.00 per share.

• Gross proceeds: $131.3 million
• Net proceeds: approximately $126.3 million after underwriting discounts and expenses
• Total shares sold under offering: 4,057,460 (3,528,226 base + 529,234 over-allotment)
• Purpose of funds: not specified in the filing

The transaction modestly increases the share count but strengthens the company’s cash position, reflecting strong investor demand for the equity issuance.

Positive

• $126.3 million net cash inflow enhances liquidity without raising debt
• Full over-allotment uptake indicates strong investor demand at $248 per share

Negative

• Issuance of 529,234 new shares creates minor dilution for existing shareholders
• No disclosure of specific use of proceeds, leaving strategic benefit unclear

Insights

Financial Analyst

TL;DR: Over-allotment adds $126 M cash; minor dilution, neutral-to-slightly positive liquidity impact.

The full take-up of the greenshoe signals healthy demand for AVAV’s equity at a relatively high price point. The added $126.3 million increases financial flexibility—potentially useful for R&D or acquisitions—without incurring debt. Dilution is limited (~2 % of pre-deal shares) and was anticipated when the base deal priced. Absent guidance on use of proceeds, the event is viewed as capital-structure neutral with a slight liquidity benefit.

Equity Capital-Markets Specialist

TL;DR: Greenshoe exercised, indicating strong book; minor EPS dilution offset by cash.

Full greenshoe execution within two weeks suggests the syndicate placed shares efficiently and market absorption was robust. Proceeds at $248 imply minimal discount to prevailing trading levels, limiting perception of value leakage. From an ECM standpoint, this is a textbook execution, enhancing cash reserves without leverage. Overall market impact should be muted; liquidity benefit could marginally improve credit profile.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-261866

Issuer:	Cartesian Growth Corp II
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	505 Fifth Avenue, 15th Floor
	New York	NEW YORK	10017
Telephone number:					(917) 543-0906

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Ordinary Shares, Units, Warrants

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-15	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many additional AeroVironment (AVAV) shares were issued on July 15, 2025?

The company issued 529,234 shares pursuant to the over-allotment option.

What proceeds did AVAV receive from the over-allotment exercise?

Gross proceeds were $131.3 million; net proceeds after expenses were approximately $126.3 million.

At what price were the additional AVAV shares sold?

Shares were sold at the original $248.00 per-share offering price.

Does this transaction increase AeroVironment's debt?

No, the capital was raised through equity, adding cash without new debt.

What is the potential impact on existing shareholders?

Share count rises by about 2 %, causing minor dilution but improving corporate liquidity.